Table of Content

Table of Contents

Global Diabetes Stem Cell Therapy Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Diabetes Stem Cell Therapy Market by Value
2.2.1 Global Diabetes Stem Cell Therapy Revenue by Type
2.2.2 Global Diabetes Stem Cell Therapy Market by Value (%)
2.3 Global Diabetes Stem Cell Therapy Market by Production
2.3.1 Global Diabetes Stem Cell Therapy Production by Type
2.3.2 Global Diabetes Stem Cell Therapy Market by Production (%)

3. The Major Driver of Diabetes Stem Cell Therapy Industry
3.1 Historical & Forecast Global Diabetes Stem Cell Therapy Demand
3.2 Largest Application for Diabetes Stem Cell Therapy (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Diabetes Stem Cell Therapy Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Diabetes Stem Cell Therapy Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Diabetes Stem Cell Therapy Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Diabetes Stem Cell Therapy Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Diabetes Stem Cell Therapy Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Diabetes Stem Cell Therapy Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Diabetes Stem Cell Therapy Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Diabetes Stem Cell Therapy Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Diabetes Stem Cell Therapy Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Diabetes Stem Cell Therapy Average Price Trend
12.1 Market Price for Each Type of Diabetes Stem Cell Therapy in US (2018-2022)
12.2 Market Price for Each Type of Diabetes Stem Cell Therapy in Europe (2018-2022)
12.3 Market Price for Each Type of Diabetes Stem Cell Therapy in China (2018-2022)
12.4 Market Price for Each Type of Diabetes Stem Cell Therapy in Japan (2018-2022)
12.5 Market Price for Each Type of Diabetes Stem Cell Therapy in India (2018-2022)
12.6 Market Price for Each Type of Diabetes Stem Cell Therapy in Korea (2018-2022)
12.7 Market Price for Each Type of Diabetes Stem Cell Therapy in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Diabetes Stem Cell Therapy Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Diabetes Stem Cell Therapy

14. Diabetes Stem Cell Therapy Competitive Landscape
14.1 ViaCyte
14.1.1 ViaCyte Company Profiles
14.1.2 ViaCyte Product Introduction
14.1.3 ViaCyte Diabetes Stem Cell Therapy Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Sernova
14.2.1 Sernova Company Profiles
14.2.2 Sernova Product Introduction
14.2.3 Sernova Diabetes Stem Cell Therapy Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Semma Therapeutics (Vertex)
14.3.1 Semma Therapeutics (Vertex) Company Profiles
14.3.2 Semma Therapeutics (Vertex) Product Introduction
14.3.3 Semma Therapeutics (Vertex) Diabetes Stem Cell Therapy Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Caladrius Biosciences
14.4.1 Caladrius Biosciences Company Profiles
14.4.2 Caladrius Biosciences Product Introduction
14.4.3 Caladrius Biosciences Diabetes Stem Cell Therapy Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Novo Nordisk
14.5.1 Novo Nordisk Company Profiles
14.5.2 Novo Nordisk Product Introduction
14.5.3 Novo Nordisk Diabetes Stem Cell Therapy Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Throne Biotechnologies Inc
14.6.1 Throne Biotechnologies Inc Company Profiles
14.6.2 Throne Biotechnologies Inc Product Introduction
14.6.3 Throne Biotechnologies Inc Diabetes Stem Cell Therapy Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Athersys
14.7.1 Athersys Company Profiles
14.7.2 Athersys Product Introduction
14.7.3 Athersys Diabetes Stem Cell Therapy Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Diabetes Stem Cell Therapy Industry (Volume)
Figure 2. Diabetes Stem Cell Therapy Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Diabetes Stem Cell Therapy Revenue in 2022
Figure 5. US Diabetes Stem Cell Therapy Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Diabetes Stem Cell Therapy Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Diabetes Stem Cell Therapy Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Diabetes Stem Cell Therapy Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Diabetes Stem Cell Therapy Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Diabetes Stem Cell Therapy Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Diabetes Stem Cell Therapy Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Diabetes Stem Cell Therapy Revenue, by Type (Million USD) (2018-2028)
Table 4. Diabetes Stem Cell Therapy Production, by Type (K Unit) (2018-2028)
Table 5. Diabetes Stem Cell Therapy Demand (K Unit) by Application (2018-2028)
Table 6. Diabetes Stem Cell Therapy Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Diabetes Stem Cell Therapy Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Diabetes Stem Cell Therapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Diabetes Stem Cell Therapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Diabetes Stem Cell Therapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Diabetes Stem Cell Therapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Diabetes Stem Cell Therapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Diabetes Stem Cell Therapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Diabetes Stem Cell Therapy Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Diabetes Stem Cell Therapy in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Diabetes Stem Cell Therapy in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Diabetes Stem Cell Therapy in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Diabetes Stem Cell Therapy in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Diabetes Stem Cell Therapy in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Diabetes Stem Cell Therapy in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Diabetes Stem Cell Therapy in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. ViaCyte Profiles
Table 61. ViaCyte Diabetes Stem Cell Therapy Product Introduction
Table 62. ViaCyte Diabetes Stem Cell Therapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. ViaCyte Strategic initiatives
Table 64. Sernova Profiles
Table 65. Sernova Diabetes Stem Cell Therapy Product Introduction
Table 66. Sernova Diabetes Stem Cell Therapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Sernova Strategic initiatives
Table 68. Semma Therapeutics (Vertex) Profiles
Table 69. Semma Therapeutics (Vertex) Diabetes Stem Cell Therapy Product Introduction
Table 70. Semma Therapeutics (Vertex) Diabetes Stem Cell Therapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Semma Therapeutics (Vertex) Strategic initiatives
Table 72. Caladrius Biosciences Profiles
Table 73. Caladrius Biosciences Diabetes Stem Cell Therapy Product Introduction
Table 74. Caladrius Biosciences Diabetes Stem Cell Therapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Caladrius Biosciences Strategic initiatives
Table 76. Novo Nordisk Profiles
Table 77. Novo Nordisk Diabetes Stem Cell Therapy Product Introduction
Table 78. Novo Nordisk Diabetes Stem Cell Therapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Novo Nordisk Strategic initiatives
Table 80. Throne Biotechnologies Inc Profiles
Table 81. Throne Biotechnologies Inc Diabetes Stem Cell Therapy Product Introduction
Table 82. Throne Biotechnologies Inc Diabetes Stem Cell Therapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Throne Biotechnologies Inc Strategic initiatives
Table 84. Athersys Profiles
Table 85. Athersys Diabetes Stem Cell Therapy Product Introduction
Table 86. Athersys Diabetes Stem Cell Therapy Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Athersys Strategic initiatives